Samarth Kulkarni, CEO: Crispr Therapeutics CRSP Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $3,613,800
Shares · price: 60,000 sh · $60.23 a share
Held after: 134,201 sh
Stock: Crispr Therapeutics CRSP
Person: Samarth KulkarniCEO
Trade date: 26/01/22
Filed: 26/01/22
Days to filing: 0 days

Sold 30.9% of holdings

Share of holding sold: 30.9%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Samarth Kulkarni's recent trades

Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$468.7K
10,020 sh
$468.7K
Filed 03/24
Traded 03/23
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$499.4K
10,349 sh
$499.4K
Filed 03/17
Traded 03/16
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$517.3K
9,798 sh
$517.3K
Filed 03/12
Traded 03/11
Samarth KulkarniCEO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$366.3K
6,967 sh
$366.3K
Filed 02/20
Traded 02/19
Samarth KulkarniCEO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$1.1M
21,433 sh
$1.1M
Filed 01/22
Traded 01/20

Samarth Kulkarni, CEO — sold $3.6M of Crispr Therapeutics CRSP · 30.9% of holdings · 10b5-1 plan | Whalegun